Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 3, 2025
Reporting period
Not applicable
Filed with the SEC
Nov 4, 2025
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-25-008911
Filed / recorded
Nov 4, 2025, 9:15 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
BOSTON SCIENTIFIC CORP
Issuer CIK
885725
Ticker
BSX
Reporting person
Joseph Michael Fitzgerald
Relationship
Officer
Officer title
EVP & Group Pres, Cardiology
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Nov 3, 2025
Transaction code
M
Shares / units
50,000
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 27, 2025.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2018, the first anniversary of the date of grant.